Moderna Inc (NAS:MRNA)
$ 127.575 1.905 (1.52%) Market Cap: 48.89 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.81 GF Score: 68/100

Moderna Inc Omicron Booster Strategy Update - Corporate Call Transcript

Dec 20, 2021 / 01:00PM GMT
Release Date Price: $276.38 (-6.25%)
Operator

Good morning, and welcome to Moderna's conference call. (Operator Instructions) Please be advised that this call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Thank you, Catherine. Good morning, everyone, and thank you for joining us on today's call to discuss data and updates to our booster strategy against Omicron. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website.

Speaking on today's call is Stephen Hoge, our President. Joining Stephen during the Q&A section is Stephane Bancel, our Chief Executive Officer; Paul Burton, our Chief Medical Officer; Jackie Miller, Senior Vice President and Head of Infectious Disease; and David Meline, our Chief Financial Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot